Champions Oncology Inc (CSBR) stock news · rev $59.4M
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
This CSBR news page leads with what Champions Oncology Inc filed — not a scraped headline mill.
No cached 8-K sentence for CSBR yet. We will not pad this page with generic market recap.
Latest reported CSBR revenue for 2026-04-30 was $59.4M. Net income was -$1.2M. Revenue was up 4.4% from 2025-04-30 to 2026-04-30. CSBR currently screens at market cap $99.8M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the CSBR stock page; for the tape open the quote page.
CSBR stock news FAQ
What are CSBR's latest revenue and net income?
Latest cached Champions Oncology Inc (CSBR) revenue for Apr 30, 2026 was $59.4M. Net income was -$1.2M. Statements: https://lician.com/financials/csbr
How did CSBR revenue change from the prior cached period?
Cached Champions Oncology Inc (CSBR) revenue was up 4.4% from $56.9M (Apr 30, 2025) to $59.4M (Apr 30, 2026). Statements: https://lician.com/financials/csbr
What is CSBR's market cap?
Champions Oncology Inc (CSBR) market cap is $99.8M on the latest cached fundamentals snapshot.
What kind of company is CSBR?
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Where is CSBR stock news listed?
Cached stock news for Champions Oncology Inc (CSBR) is listed at https://lician.com/news/csbr. Filings: https://lician.com/sec/csbr
Not investment advice.